Hill, Michael P <br/><br/>
Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets: Mediation by D2, not D3, dopamine receptors.  [electronic resource] 

 -  Movement disorders : official journal of the Movement Disorder Society  Dec 2006 
 - 2090-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0885-3185 
<br/><br/><label>Standard No.: </label>10.1002/mds.21106  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analysis of Variance<br/>Animals<br/>Antiparkinson Agents--therapeutic use<br/>Behavior, Animal--drug effects<br/>Callithrix<br/>Disease Models, Animal<br/>Dopamine Antagonists--therapeutic use<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Indoles--therapeutic use<br/>Levodopa--therapeutic use<br/>MPTP Poisoning--drug therapy<br/>Motor Activity--drug effects<br/>Oxazines--therapeutic use<br/>Piperidines--therapeutic use<br/>Receptors, Dopamine D2--physiology<br/>Receptors, Dopamine D3--physiology<br/>Time Factors